Fraz Ismat is trained in Internal Medicine, Paediatrics & Paediatric Cardiology. Following his training in clinical medicine and cardiovascular developmental biology, Dr. Ismat has been working drug development.
Safety, tolerability, and pharmacokinetics (PK) of treprostinil palmitil inhalation powder (TPIP): a phase 1, randomised, double-blind, single- and multiple-dose study
Event: ESC Congress 2021 - The Digital Experience
Topic: Pulmonary Hypertension
Session: Pulmonary arterial hypertension: risk stratification guides for new treatments and informed outcomes
